M. Kathleen Behrens, Director at IGM Biosciences, Inc. (IGMS), bought 62,500 shares at $16.00 ($1.0M) on 2019-09-18, disclosed to the SEC on 2019-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| IGMS | BUY | 2022-04-04 | $1.4M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $429K | — | Filing → |
| IGMS | BUY | 2020-12-15 | $3.0M | — | Filing → |